Immunological selection for Leishmania (Viannia) braziliensis antigens

Annals of Tropical Medicine and Parasitology

Volumn 95, Issue 5, 2001, Pages 473-483

  Cuba Cuba, C A ^a   Ogunkolade, W ^a   Howard, M K ^a   Miles, M A ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; NONHUMAN; PROGNOSIS; PROTOZOAL INFECTION; SEROLOGY;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

LEISHMANIA BRAZILIENSIS; PROTOZOA; TRYPANOSOMATIDAE; VIANNIA;

EID: 0034906284     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034980120076226     Document Type: Article

References (30)

1. Dissemination of Leishmania (Viannia) braziliensis
2. A putative Leishmania panamensis/Leishmania braziliensis hybrid is a causative agent of human cutaneous leishmaniasis in Nicaragua
3. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis
4. Human mucocutaneous leishmaniasis in Tres Bracos, Bahia, Brazil. An area of Leishmania braziliensis braziliensis transmission. I. Laboratory diagnosis
5. Intergenic region typing (IRT): A rapid molecular approach to the characterization and evolution of Leishmania
6. Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot
7. A review of the geographic distribution and epidemiology of leishmaniasis in the New World
8. Identification and purification of a 72 kDa antigen of Leishmania braziliensis braziliensis present on the surface and in the cytoplasm of the promastigotes and its specific recognition by sera from mucocutaneous leishmaniasis patients
9. Antigenic specificity of the 72-kilodalton major surface glycoprotein of Leishmania braziliensis braziliensis
10. Evolution, classification and geographical distribution
11. A rapid multicolour western blot
12. Evidence for a 72 kDa specific surface in Leishmania braziliensis braziliensis
13. South American trypanosomiasis and leishmaniasis: Endemic diseases of continental dimensions affecting poor, neglected, and underfunded people
14. Human mucocutaneous leishmaniasis in Tres Bracos, Bahia, Brazil. An area of Leishmania braziliensis braziliensis transmission. III. Mucosal disease. Presentation and initial evolution
15. Analysis of the specificity of human antibodies to antigens of Leishmania braziliensis braziliensis
16. Loss of the GP46/M-2 surface membrane glycoprotein gene family in the Leishmania braziliensis complex
17. Immunoselection techniques for cloning DNA-encoding parasite-specific antigens
18. Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with glucantime
19. An evolutionary study of mucosal leishmaniasis (a 7- to 17-year follow-up) due to Leishmania (Viannia) braziliensis in Tres Bracos, Bahia
20. Cytokine patterns in the pathogenesis of human leishmaniasis
21. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera
22. Predominance of Leishmania (Viannia) brazihensis in the regions of Tres Bracos and Corte de Pedra, Bahia, Brazil
23. Western blot analysis of humoral response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis
24. Human visceral leishmaniasis: Analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi
25. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis
26. Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans
27. Humoral immune responses among mucosal and cutaneous leishmaniasis patients Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis